NASDAQ: MMSI
Merit Medical Systems Inc Stock

$67.22+1.98 (+3.03%)
Updated Jun 18, 2026
MMSI Price
$67.22
Fair Value Price
$149.92
Market Cap
$4.01B
52 Week Low
$59.74
52 Week High
$96.74
P/E
28.6x
P/B
2.47x
P/S
2.66x
PEG
1.06x
Dividend Yield
N/A
Revenue
$1.54B
Earnings
$139.34M
Gross Margin
48.7%
Operating Margin
13.81%
Profit Margin
9%
Debt to Equity
0.67
Operating Cash Flow
$297M
Beta
0.84
Next Earnings
Jul 30, 2026
Ex-Dividend
N/A
Next Dividend
N/A

MMSI Overview

Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MMSI's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical

Industry Rating
A
MMSI
Ranked
#4 of 42

Top Ranked Stocks in Industry

View Top Medical Stocks

Be the first to know about important MMSI news, forecast changes, insider trades & much more!

MMSI News

Overview

Due Diligence Score

–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MMSI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MMSI ($67.22) is undervalued by 55.16% relative to our estimate of its Fair Value price of $149.92 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MMSI ($67.22) is significantly undervalued by 55.16% relative to our estimate of its Fair Value price of $149.92 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MMSI ($67.22) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MMSI due diligence checks available for Premium users.

Valuation

MMSI fair value

Fair Value of MMSI stock based on Discounted Cash Flow (DCF)

Price
$67.22
Fair Value
$149.92
Undervalued by
55.16%
MMSI ($67.22) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MMSI ($67.22) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MMSI ($67.22) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MMSI price to earnings (PE)

For valuing profitable companies with steady earnings

Company
28.6x
Industry
42.33x
Market
9.47x
MMSI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MMSI is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

MMSI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.47x
Industry
3.15x
MMSI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MMSI price to earnings growth (PEG)

For valuing profitable companies with growth potential

MMSI is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

MMSI's financial health

Profit margin

Revenue
$381.9M
Net Income
$41.0M
Profit Margin
10.7%
MMSI's Earnings (EBIT) of $212.94M... subscribe to Premium to read more.
Interest Coverage Financials
MMSI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.7B
Liabilities
$1.1B
Debt to equity
0.67
MMSI's short-term assets ($1.10B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MMSI's short-term assets ($1.10B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MMSI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MMSI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$40.7M
Investing
$7.7M
Financing
-$6.3M
MMSI's operating cash flow ($297.48M)... subscribe to Premium to read more.
Debt Coverage Financials

MMSI vs Medical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MMSIB$4.01B+3.03%28.60x2.47x
NVSTB$4.22B+4.22%61.69x1.37x
ICUIB$3.51B+1.76%75.06x1.66x
HAEB$3.37B+1.98%36.00x4.23x
WRBYC$3.19B+7.18%1,298.00x8.48x

Merit Medical Systems Stock FAQ

What is Merit Medical Systems's quote symbol?

(NASDAQ: MMSI) Merit Medical Systems trades on the NASDAQ under the ticker symbol MMSI. Merit Medical Systems stock quotes can also be displayed as NASDAQ: MMSI.

If you're new to stock investing, here's how to buy Merit Medical Systems stock.

What is the 52 week high and low for Merit Medical Systems (NASDAQ: MMSI)?

(NASDAQ: MMSI) Merit Medical Systems's 52-week high was $96.74, and its 52-week low was $59.74. It is currently -30.51% from its 52-week high and 12.52% from its 52-week low.

How much is Merit Medical Systems stock worth today?

(NASDAQ: MMSI) Merit Medical Systems currently has 59,654,855 outstanding shares. With Merit Medical Systems stock trading at $67.22 per share, the total value of Merit Medical Systems stock (market capitalization) is $4.01B.

Merit Medical Systems stock was originally listed at a price of $1.80 in Dec 31, 1997. If you had invested in Merit Medical Systems stock at $1.80, your return over the last 28 years would have been 3,634.44%, for an annualized return of 13.8% (not including any dividends or dividend reinvestments).

How much is Merit Medical Systems's stock price per share?

(NASDAQ: MMSI) Merit Medical Systems stock price per share is $67.22 today (as of Jun 18, 2026).

What is Merit Medical Systems's Market Cap?

(NASDAQ: MMSI) Merit Medical Systems's market cap is $4.01B, as of Jun 20, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Merit Medical Systems's market cap is calculated by multiplying MMSI's current stock price of $67.22 by MMSI's total outstanding shares of 59,654,855.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.